TTK Healthcare has fixed Friday, July 17, 2026, as the record date to determine the voting rights of shareholders and beneficial owners for the declaration of dividend. The record date serves as the cut-off for establishing entitlements ahead of the company's upcoming Annual General Meeting.

The 68th Annual General Meeting of TTK Healthcare Limited is scheduled to be held at 12.00 noon on Friday, July 24, 2026. The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in compliance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India.

The filing was submitted to BSE Limited and the National Stock Exchange of India Limited on June 03, 2026. The disclosure was made by Gowry A Jaishankar, DGM – Legal & Company Secretary.

Key Event Details

TTK Healthcare reported a 19.6% decline in net profit for the year ended March 31, 2026, to ₹656.8 crore, despite a 7% rise in revenue from operations to ₹8,572.8 crore. The decline was primarily due to exceptional charges amounting to ₹757.87 lakh recognized in the third quarter, resulting from the incremental impact of new Labour Codes. The board recommended a dividend of ₹10 per equity share, subject to shareholder approval at the Annual General Meeting, and approved the reappointment of Mr. T T Raghunathan as Executive Chairman for a further term of five years effective from November 1, 2026.

For the fourth quarter ended March 31, 2026, the company posted a net profit of ₹217.6 crore, a significant increase from ₹161.5 crore in the corresponding period of the previous year. Revenue from operations for the quarter stood at ₹2,179.8 crore, compared to ₹1,903.6 crore in Q4 FY25. The statutory auditors, M/s PKF Sridhar & Santhanam LLP, issued an unmodified opinion on the audited financial results.

Financial Results for FY26

The following table summarizes the audited financial results for the year ended March 31, 2026:

Q4 Performance Snapshot

The following table highlights the key quarterly metrics for the period ended March 31, 2026:

Segment Performance

Revenue growth was driven by the Protective Devices and Foods segments. The Protective Devices segment reported annual revenue of ₹2,165.1 crore, while the Foods segment recorded ₹1,511 crore. The Medical Devices segment contributed ₹1,069.2 crore to the total revenue. However, the Protective Devices segment reported a loss before tax and interest of ₹105.4 crore for the year, compared to a profit of ₹25.3 crore in the previous year.

Board Decisions

The Board of Directors approved the reappointment of Mr. T T Raghunathan (DIN: 00043455) as Executive Chairman (Wholetime Director) for a term of five years from November 1, 2026. The remuneration was fixed based on the recommendations of the Nomination and Remuneration Committee. The board also appointed M/s Geeyes & Co. as the Cost Auditor for FY 2026-27 and fixed their remuneration, subject to ratification by shareholders. The 68th AGM is scheduled for July 24, 2026, via Video Conferencing.